Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
BioAtla, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 8-K Quarterly results
05/11/2023 8-K Quarterly results
Docs: "BIOATLA REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS"
03/23/2023 8-K Quarterly results
Docs: "BIOATLA REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS"
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"BioAtla Announces Change in Executive Leadership SAN DIEGO, February 27, 2023 - BioAtla, Inc. , a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic antibody therapeutics for the treatment of solid tumors, today announced that its President, Scott Smith, will be leaving the Company to pursue a new opportunity as Chief Executive Officer at Viatris , a large, global healthcare pharmaceutical company. Scott will continue his relationship with BioAtla by serving as a Board of Directors member for the Company. “We extend our sincere thanks to Scott for his important contributions since joining the Company in 2018 and wish him well in his new endeavor,” said Jay M. Short, Ph.D., Chairman, Chief Executive Officer and co-founder of BioAtla. “Sco..."
01/06/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Open Market Sale AgreementSM, between BioAtla, Inc. and Jefferies LLC",
"Opinion of Orrick, Herrington & Sutcliffe LLP"
11/07/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, by and between BioAtla, Inc. and J.P. Morgan Securities LLC",
"Opinion of Orrick, Herrington & Sutcliffe LLP related to the Shares"
11/04/2022 8-K Investor presentation
Docs: "Corporate Presentation",
"Corporate Presentation"
11/03/2022 8-K Quarterly results
09/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BIOATLA, INC."
08/09/2022 8-K Quarterly results
Docs: "BIOATLA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS"
06/17/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
Docs: "BIOATLA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS"
04/11/2022 8-K Investor presentation
Docs: "Slide Presentation",
"Slide Presentation"
02/25/2022 8-K Quarterly results
12/21/2021 8-K Quarterly results
11/19/2021 8-K Termination of a Material Definitive Agreement  Interactive Data
09/29/2021 8-K Quarterly results
06/16/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/09/2021 8-K Quarterly results
12/18/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 18, 2020 BioAtla, Inc. Delaware 001-39787 85-1922320 11085 Torreyana Road San Diego, California 92121 558-0708 n/a Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchang...",
"Amended and Restated Certificate of Incorporation of BioAtla, Inc",
"Amended and Restated Bylaws of BioAtla, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy